System Transmission

Top Signal

100#1 JOB

Activity

2186Ripe

+960 today

System

Live1m

Terminal Asset View

stockNASDAQ

CELU

$1.22-3.94%

Celularity Inc - Class A

Overripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

26Overripe

Live Analysis Active

Company Mission

Celularity develops medical treatments using cells derived from the placenta after healthy births. Their therapies target conditions like cancer, immune disorders, and aging-related diseases. The company makes money through research partnerships with other biotech firms, licensing agreements, and advancing treatments through clinical trials to eventually bring them to market.

CEL

Industry Context

Celularity operates in the biotechnology sector, which focuses on developing medical treatments using living cells. This industry is known for high research costs and long development timelines, but successful treatments can be very valuable. Companies in this space often partner with larger pharmaceutical firms or universities to advance their research.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

77Matrix

Market Momentum

46.3— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.4x— Normal Volume

Today's Change

-3.94%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing CELU across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:02 PM UTC

As-of 03-14-2026 17:47 UTC

Develops cell-based therapies using placental cells to treat cancer and immune diseases, earning money by selling treatments to hospitals and clinics.

Price below key moving averages, suggesting the stock is in a downtrend that needs to be watched carefully showing consolidation pattern.

Technical squeeze pattern detected, indicating potential for a significant price move when volatility returns to normal levels, suggesting normal.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...